[breadcrumb_custom]

Tag: QIAGEN N.V.

Markets

QIAGEN N.V. (NYSE:QGEN): A Fundamentally Weighted Stock for Long-Term Investors

QIAGEN N.V. (NYSE:QGEN) shares fell to a low of $47.68 before closing at $48.03. Intraday shares traded counted 0.61 million, which was 12.01% higher than

Companies

Something To Watch Before Buying QIAGEN N.V. (NYSE:QGEN)

QIAGEN N.V. (NYSE:QGEN) previous close was $46.91 while the outstanding shares total 232.31M. The firm has a beta of 0.25, a 12-month trailing P/E ratio

Finance

QIAGEN N.V. (NYSE:QGEN) Undervalued? Fundamentals Hard To Beat?

QIAGEN N.V. (NYSE:QGEN) Relative Strength Index (RSI) is 57.38, with weekly volatility at 0.95% and ATR at 0.84. The QGEN stock’s 52-week price range has

Industry

QIAGEN N.V. (NYSE:QGEN): An Opportunity for Fundamental Investors?

QIAGEN N.V. (NYSE:QGEN) has a beta of 0.25, a 12-month trailing P/E ratio of 25.72, and a growth ratio of 2.45. The stock’s Relative Strength

Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.

Quick Links

About Us

Our Team

Disclaimer

Tag: QIAGEN N.V.

QIAGEN N.V. (NYSE:QGEN): A Fundamentally Weighted Stock for Long-Term Investors

Something To Watch Before Buying QIAGEN N.V. (NYSE:QGEN)

QIAGEN N.V. (NYSE:QGEN) Undervalued? Fundamentals Hard To Beat?

QIAGEN N.V. (NYSE:QGEN): An Opportunity for Fundamental Investors?

Quick Links

Categories